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Abstract
Background: Serrated polyps belong to a heterogeneous group of lesions that are generally characterized
morphologically. This type of lesion is thought to be the precursor of sporadic carcinomas with microsatellite
instability, and probably also the precursor for CpG island-methylated microsatellite-stable carcinomas. For practical
purposes, according to the 2010 WHO classification, the diagnostic criteria for sessile serrated adenomas/polyps
(SSA/Ps) was established by the research project “Potential of Cancerization of Colorectal Serrated Lesions” led by
the Japanese Society for Cancer of the Colon and Rectum. The aim of this study was to evaluate the validity of the
morphologic characteristics established in Japan by using immunohistochemical staining for Ki-67.
Methods: To calculate the target cells, 2 contiguous crypts which could be detected from the bottom of the crypt
to the surface of the colorectal epithelium were selected. To validate the proliferative activity, we evaluated the
percentage and the asymmetrical staining pattern of Ki67 positive cells in each individual crypt. To examine the
immunoreactivity of Ki67, computer-assisted cytometrical analysis was performed.
Results: SSA/Ps had a higher proliferative activity as compared to hyperplastic polyps (HPs) based on the difference
in incidence of Ki67 positive cells, and the former also exhibited a significantly higher asymmetric distribution of
these cells as compared to HPs, even in lesions with a diameter <10 mm.
Conclusion: We conclude that assessment of the pathological findings of SSA/Ps, including crypt dilation,
irregularly branching crypts, and horizontally arranged basal crypts (inverted T- and/or L-shaped crypts) is
appropriate to show a significantly higher proliferative activity as compared to HPs. Further, the use of
two-dimensional image analysis software is an objective and reproducible method for this type of histological
examination.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
6718091416698112
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Background
The new concept of the serrated pathway was proposed
by Snover et al., although it is assumed that all colorectal
carcinomas arise from sporadic adenomas (the Fearon-
Vogelstein model) or de-novo carcinogenesis [1]. Ser-
rated polyps belong to a heterogeneous group of lesions
that are classified according to their morphology/
morphological phenotypes. These types of lesions are
thought to be the precursor of sporadic carcinomas with
microsatellite instability (MSI) and are probably also
the precursor for CpG island-methylated microsatellite-
stable carcinomas [2-4]. In 1996, a report by Torlakovic
and Snover et al. showed lesions that bore some resem-
blance to hyperplastic polyps (HPs), which were found
in association with the development of adenocarcinoma
[5]. In 2003, a subsequent report demonstrated that
these lesions, which had been mistaken for HPs, were
found to account for 18% of all serrated polyps. They
designated these lesions as “sessile serrated adenomas/
polyps” (SSA/Ps) to distinguish them from conventional
HPs [6]. In 2010, the morphology of SSA/Ps, character-
ized by a serrated architecture of the epithelial compart-
ment, was first presented in the fourth edition of the
WHO Classification of Tumors of the Digestive System
[7]. For practical purposes, according to the WHO clas-
sification, the diagnostic criteria for SSA/Ps was estab-
lished by the research project “Potential of Cancerization
of Colorectal Serrated Lesions” led by the Japanese
Society for Cancer of the Colon and Rectum (Yao T,
et al) [8]. The aim of the current study was to evaluate
the validity of the morphologic characteristics established
in Japan using immunohistochemical staining for Ki-67.
Methods
Tissue samples and histology
Two hundred and seventy-nine specimens from 223
patients were derived from the Department of Pathology
archives of Dokkyo Medical University between July
2008 and December 2010. Sixty cases obtained by biopsy,
90 cases by colonoscopic polypectomy, and 88 cases by
endoscopic resection were included in the initial assess-
ment. The fourth edition of the WHO Classification of
Tumors of the Digestive System was used to distinguish
HPs and SSA/Ps from other polyps. As described above,
SSA/Ps were distinguished from conventional HPs on
the basis of the following features: 1) crypt dilation, 2)
irregularly branching crypts, and 3) horizontally arranged
basal area of the crypts (inverted T- and/or L-shaped
crypts). The serrated lesions which had more than 2 of
these findings were diagnosed as SSA/Ps, and those with
only one of these findings were designated as intermedi-
ate type. Others that contained none of these features
were regarded as HPs. Because of sampling issues or
poor orientation of the specimen, some of the polyps
were excluded. Finally, 68 cases were used for the com-
parison. The authors and a pathologist (T.F.) examined all
samples.Hematoxylin and eosin staining was performed
as usual.Hematoxylin and eosin-stained sections of each
sample were employed for pathological examinations.
Immunohistochemical staining for Ki67
Immunohistochemical staining for Ki67 was performed
with a LSAB-2 kit (LSAB2 System-HRP; DAKO, Carpin-
teria, CA, USA) as described previously [9,10]. The
4 μm thick sections were placed on slides, deparaffi-
nized, and dehydrated. They were then placed in 0.01 M
citrate buffer (pH 6.0) and treated by microwave heat-
ing (400 W, 95°C; MI-77; Azumaya, Tokyo, Japan) for
40 minutes to facilitate antigen retrieval. Then, the sec-
tions were pretreated with 0.3% H2O2 in methanol at
room temperature to quench endogenous peroxidase
activity. This was followed by blocking with Protein
Block Serum-Free (Dako, USA) for 30 minutes, and
incubation with anti-Ki-67 antibody (1:50 clone MIB-1;
Dako, Japan) for 1 hour. Thereafter, the sections were
incubated with biotinylated secondary antibody for
15 minutes, washed with PBS, and treated with peroxid-
ase-conjugated streptavidin for 20 min. Finally, the sections
were visualized by incubating in 3, 3′-diaminobenzidine
tetrahydrochloride with 0.05% H2O2 (Liquid DAB + Sub-
strate Chromogen System; Dako, USA) for 3 min and then
counterstained with Carazzi’s hematoxylin.
Evaluation of immunohistochemical Ki67 expression
To assess the target cells, 2 contiguous crypts which
could be visualized from the bottom of the crypt to the
surface of the colorectal epithelium were selected.
Immunostained sections were evaluated by 3 of the
authors and a pathologist, and Ki-67 positivity was eval-
uated as described previously. In our first evaluation, the
proportion of Ki-67 positive cells was calculated as the
percentage of positive cells in 2 crypts. In the second
step, to evaluate the asymmetrical staining pattern of
Ki-67 positive cells in each individual crypt, the distance
between the immunopositive cells located closest to the
surface and the bottom of the crypt was measured.
Computer-assisted cytometrical analysis of Ki-67 immu-
noreactivity was performed using the WinROOF image
processing software (Mitani Corp., Tokyo, Japan) [11].
Statistical analysis
The proportion of Ki-67 positively-stained cells and the
asymmetrical location of proliferating cells on either
side of the crypts were analyzed by the Mann–Whitney
U-test. Continuous variables were expressed as mean ± SD
or, where indicated, as median and interquartile range
(IQR). A P-value< 0.05 was considered significant.




Histological examination of the Hematoxylin and eosin-
stained specimens of the 68 serrated polyps without
cytological dysplasia showed that 14 of them were HPs
and 24 were SSA/Ps (Figure 1), while 30 were of the
intermediate type. Clinicopathologic characteristics of
SSA/P, HP, and intermediate type polyps are shown in
Table 1. The percentage of females with SSA/Ps was
higher than that with HPs. The mean size of SSA/Ps
(mean 9 mm; range 7–15 mm) was larger than that of
HPs (mean 5 mm; range 2–8 mm). Forty-two percent of
SSA/Ps was over 10 mm in size. The percentage of SSA/
Ps on the right side of the colon was more frequent than
that of HPs. Macroscopic flat-elevated findings tended to
be higher in SSA/Ps compared with HPs. Further, the
mean size of the intermediate type polyps (mean 7 mm;
range 5–10 mm) was larger than that of HPs but smaller
than that of SSA/Ps. There were no statistically signifi-
cant differences in age distribution and location between
the intermediate type and the other two types (Table 2).
Immunohistochemical Ki-67 expression in SSA/Ps and HPs
The percentage of Ki-67 positive cells in the SSA/Ps
(mean 43.4%, range 35.5–50.3%) (Figure 2) was signifi-
cantly higher than that in the HPs (mean 30.9%, range
22.8–34.5%) (p= 0.00019) (Figure 3). There was also a
statistically significant difference in the distribution of
Ki-67 positive cells between SSA/Ps (mean 12.9%, range
8.7–18.1%) and HPs (mean 8.3%, range 6.9–10.4%)
(p= 0.00562) (Table 3).
In addition, we evaluated the percentage and the
asymmetrical staining pattern of the Ki-67 positive cells
in each individual crypt in lesions with a diameter
<10 mm. For this purpose, fourteen cases of SSA/Ps
and 12 cases of HPs were selected. The percentage of
Ki-67 positive cells in lesions that were less than 10 mm
in the SSA/P cases (mean 41.75%, range 34.5–45.8%)
were significantly higher than in the HP specimens
(30.9%, 24.25–35.75%) (p= 0.00692). Further, the distri-
bution of Ki-67 cells in SSA/Ps that were less than
10 mm (11.65%, 8.3–17.9%) was more asymmetrical than
in HPs (8.65%, 5.2–10.7%) (p= 0.03075) (Table 4), a dif-
ference that was statistically significant.
Interestingly, in the intermediate type, the mean per-
centage of the positive cells was 35.85% (range 31.05–
45.35%), and the asymmetrical distribution of the Ki-67
positive cells was 11.65% (range 8.3–17.9%), values
which were intermediate between SSA/Ps and HPs.
Discussion
In our previous report, proliferative activity of the colon
epithelium was compared between SSA/Ps and HPs
using Ki-67 immunostaining [12]. Our findings showed
that the proportion of Ki-67 positive cells was higher
in SSA/Ps as compared to HPs. A difference in the
Figure 1 Characteristic histological features of SSA/P
(Hematoxylin and eosin staining). The crypts showed dilation,
serration, irreguraly branching and horizontally arranging (L-shaped,
inverted T-shaped or anchor shaped) at the base.
Table 1 Diagnostic criteria of SSA/P from Project
Research “Potential of Cancerization of Colorectal
Serrated Lesions” of Japanese Society for Cancer of
the Colon and Rectum
SSAP/P is composed of serrated cryptal epithelium with aberrant
compartmentalization, essentially characterized by the architectural
abnormalities listed below
If the serrated lesion have more than 2 findings of them, it can be
diagnosed as SSA/P
(1) Crypt dilation
(2) Irregularly branching crypts
(3)Horizontally arranged basal crypts (Inverted T- and/or L-shaped crypts)
Table 2 Clinicopathologic characteristics of SSA/P, HP and
Intermediated type






12/2 13/11 .03394 21/9
Age (y), median
(range)
52.5 (46–64) 62.5 (51.5–73) .00086 55 (51–63)
Size (mm), median
(range)
5 (2–8) 9 (7–15) 7 (5–10)
Location (%)
Right colon 3 (21) 17 (71) 15 (50)
Left colon 5 (36) 6 (25) .00209 10 (33)
Rectum 6 (43) 1 (4) 5 (17)
Endoscopic morphology
Ip 1 (7) 0 (0) 0 (0)
non-Ip 9 (64) 22 (92) <.001 24 (80)
UN 4 (29) 2 (8) 6 (20)
a Mann-Whitney U test or ×2 test.
HP: Hyperplastic polyp.
SSA/P: Sessile serrated adenoma/polyp.
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distribution pattern of the proliferative compartment
revealed that Ki-67 immunostaining is useful to differen-
tiate between SSA/Ps and HPs. However, the number of
cells was visually counted, resulting in lack of objectivity
and reproducibility of measurement. In this study, al-
though we strived to circumvent the previous issues by
counting the number of cells in microscopic images (x10)
processed by Photoshop Elements 9 using a two-dimensional
image analysis software [11], several problems still
occurred. The targeted area of the colon mucosa was
traced and defined, followed by a count of the number of
cells based on color recognition of the cells. In order to
maximally differentiate the target cells from the adjacent
ones, the margins of the nuclei were identified by enhanced
contrast for RGB separation. Although G (green) image
was the easiest to assess, maximal and accurate differenti-
ation of the targeted cells from the adjacent cells was
still not possible using just the color recognition method.
The measurement was, therefore, done with the “Separate
Circular Figure” function using the 2D Image Analysis
Software, Win-ROOF, by Mitani Corporation, Japan. The
maximum and minimum diameters of the cells, the
number of candidacy center points, edge threshold, and
contrast were set to mark the cell border and in turn,
visualize the cells as donut-shaped. Thus, the number of
cells could be more accurately counted. However, due to
the complicated adjustments of these settings, manual
counting function of the image analysis software was uti-
lized, and the number of cells was counted with a touch
pen by introducing a liquid crystal touch panel. Moreover,
the distance from the base of the crypts to the Ki-67 posi-
tive cells on the surface was also defined by a line drawn
with a touch pen and automatically measured. These mea-
surements could be automatically transferred to Microsoft
Excel and were also useful for data processing. The above-
mentioned measurements were performed as a pilot study,
which was followed by commencement of the main study.
The protein antigen Ki-67 has been widely used as an
indicator of proliferation due to its restricted expression
between the S and the M phases of the cell cycle in dif-
ferentiating cells. In this study, it was confirmed that
SSA/Ps had a higher proliferative activity as compared
to HPs as shown by the difference in incidence of Ki-67
positive cells. Furthermore, based on the assumption
that the proliferative compartment might be an indicator
of distribution range, the distance from the base of the
crypt to the Ki-67 positive cells on the surface was mea-
sured, and it was found that SSA/Ps exhibited a signifi-
cantly more asymmetric distribution compared with HPs
[13]. Moreover, it was revealed that SSA/Ps had a higher
proliferative activity with more asymmetric distribution,
as demonstrated by proportion of Ki-67 positive cells
and distance in a single crypt, respectively, as compared
to HPs even in lesions with diameter <10 mm. These
Figure 2 Immunohistochemical findings for Ki-67 in HP and
SSA/P. Ki-67 positive cells were seen in the bottom and surface of
individual crypt of HP (Figure 2) and SSA/P (Figure 3).
Figure 3 Immunohistochemical findings for Ki-67 in HP and
SSA/P. Ki-67 positive cells were seen in the bottom and surface of
individual crypt of HP (Figure 2) and SSA/P (Figure 3).
Table 3 Immunohistochemical Ki67 expression in SSA/P
and HP
HP (n=14) SSA/P (n=24) pa
Ki67 positivity* (%) 19 30.9 (22.8–34.5) 43.4 (35.5–50.3) .000
Asymmetry of the
location** (%) 62
8.3 (6.9–10.4) 12.9 (8.7–18.1) .005
a Mann-Whitney U test.
* Frequency of Ki67 positive cells.
** Asymmetry of the location of Ki67 positive cells in each individual crypt.
Table 4 Immunohistochemical Ki67 expression in SSA/P
and HP (<10mm)
HP (n=12) SSA/P (n=14) pa
Ki67 positivity* (%) .00692 30.9 (24.25–35.75) 41.75 (34.5–45.8)
Asymmetry of the
location** (%) .03075
8.65 (5.2–10.7) 11.65 (8.3–17.9)
a Mann-Whitney U test.
* Frequency of Ki67 positive cells.
** Asymmetry of the location of Ki67 positive cells in each individual crypt.
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results demonstrated that, according to the diagnostic
criteria provided in Table 1, in SSA/Ps, even lesions with
a diameter< 10 mm had a higher proliferative activity as
compared to similar sized lesions in HPs. Thus, we veri-
fied here that the common features of SSA/Ps including
crypt dilation, irregularly branching crypts, and horizon-
tally arranged basal crypts (inverted T- and/ or L-shaped
crypts) are indeed appropriate histological findings to
show “none dysplastic, but have an extended prolifera-
tive zone [14,15]” as indicated by Riddell. In this study,
the intermediate group showed intermediate characteris-
tics between HP and SSA/P, and this may be because
this type of lesion is a transitional stage from HP to
SSA/P. However, further investigation is required in
order to support this finding.
Conclusion
The pathological characters and the diagnostic criteria
for SSA/P was established by the research project “Po-
tential of Cancerization of Colorectal Serrated Lesions”
led by the Japanese Society for Cancer of the Colon and
Rectum (Y T, et al). As a result of this study, the patho-
logical features of SSA/P including crypt dilation, irregu-
larly branching crypts, and horizontally arranged basal
crypts (inverted T- and/ or L-shaped crypts) were found
to be appropriate histological findings to show a signifi-
cantly higher proliferative activity as compared to HP.
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